The British Cardiovascular Intervention Society’s (BCIS) scoring system that assesses the risk of major adverse cardiac and cerebrovascular events (MACCE) at 1 year in patients undergoing percutaneous coronary intervention (PCI) has a “good predictive value,” according to researchers.